Honest reviews of 89+ online health providers across GLP-1 weight loss, TRT, ED, hair loss, women's health, longevity, peptides, and primary care. Compare pricing, clinical oversight, and real patient experiences.
Mean body-weight change from baseline to week 68 was −15.8% with semaglutide and −6.4% with liraglutide.
Adults with obesity or overweight without diabetes who met the trial’s BMI and clinical eligibility criteria; 68 weeks. Read the linked peer-reviewed source for the full methodology, findings, and limitations.
Rubino et al., JAMA 2022 · STEP 8